Natriuretic peptide hormone measurement in acute coronary syndrome

Param Maewal; James A de Lemos

doi:10.1023/A:1026103601075

Natriuretic peptide hormone measurement in acute coronary syndrome

Param Maewal, James A de Lemos

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Cardiac ischemia is an important trigger for the release of B-type natriuretic peptide (BNP). BNP and N-terminal pro-BNP (N-proBNP) are emerging as important biomarkers for risk stratification in patients with acute coronary syndromes. Higher levels of BNP and pro-BNP are associated with a greater risk for death and heart failure, independent of traditional clinical variables and levels of other biomarkers such as troponins and C-reactive protein. The therapeutic implications of these findings are not yet known.

Original language	English (US)
Pages (from-to)	365-368
Number of pages	4
Journal	Heart Failure Reviews
Volume	8
Issue number	4
DOIs	https://doi.org/10.1023/A:1026103601075
State	Published - Oct 2003

Keywords

Acute coronary syndromes
BNP
Natriuretic peptide
Risk-stratification

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1023/A:1026103601075

Cite this

@article{e6e36857304c4e8dba0757cb55a4bb7f,

title = "Natriuretic peptide hormone measurement in acute coronary syndrome",

abstract = "Cardiac ischemia is an important trigger for the release of B-type natriuretic peptide (BNP). BNP and N-terminal pro-BNP (N-proBNP) are emerging as important biomarkers for risk stratification in patients with acute coronary syndromes. Higher levels of BNP and pro-BNP are associated with a greater risk for death and heart failure, independent of traditional clinical variables and levels of other biomarkers such as troponins and C-reactive protein. The therapeutic implications of these findings are not yet known.",

keywords = "Acute coronary syndromes, BNP, Natriuretic peptide, Risk-stratification",

author = "Param Maewal and {de Lemos}, {James A}",

note = "Funding Information: This work is supported by a career development award from Glaxo-Smith-Kline and by a grant from the Donald W. Reynolds Foundation. Dr. de Lemos has received grant support and speaker honoraria from Biosite, Inc., a company that manufactures an assay for BNP.",

year = "2003",

month = oct,

doi = "10.1023/A:1026103601075",

language = "English (US)",

volume = "8",

pages = "365--368",

journal = "Heart Failure Reviews",

issn = "1382-4147",

publisher = "Springer Netherlands",

number = "4",

}

TY - JOUR

T1 - Natriuretic peptide hormone measurement in acute coronary syndrome

AU - Maewal, Param

AU - de Lemos, James A

N1 - Funding Information: This work is supported by a career development award from Glaxo-Smith-Kline and by a grant from the Donald W. Reynolds Foundation. Dr. de Lemos has received grant support and speaker honoraria from Biosite, Inc., a company that manufactures an assay for BNP.

PY - 2003/10

Y1 - 2003/10

N2 - Cardiac ischemia is an important trigger for the release of B-type natriuretic peptide (BNP). BNP and N-terminal pro-BNP (N-proBNP) are emerging as important biomarkers for risk stratification in patients with acute coronary syndromes. Higher levels of BNP and pro-BNP are associated with a greater risk for death and heart failure, independent of traditional clinical variables and levels of other biomarkers such as troponins and C-reactive protein. The therapeutic implications of these findings are not yet known.

AB - Cardiac ischemia is an important trigger for the release of B-type natriuretic peptide (BNP). BNP and N-terminal pro-BNP (N-proBNP) are emerging as important biomarkers for risk stratification in patients with acute coronary syndromes. Higher levels of BNP and pro-BNP are associated with a greater risk for death and heart failure, independent of traditional clinical variables and levels of other biomarkers such as troponins and C-reactive protein. The therapeutic implications of these findings are not yet known.

KW - Acute coronary syndromes

KW - BNP

KW - Natriuretic peptide

KW - Risk-stratification

UR - http://www.scopus.com/inward/record.url?scp=0347525878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347525878&partnerID=8YFLogxK

U2 - 10.1023/A:1026103601075

DO - 10.1023/A:1026103601075

M3 - Review article

C2 - 14574059

AN - SCOPUS:0347525878

SN - 1382-4147

VL - 8

SP - 365

EP - 368

JO - Heart Failure Reviews

JF - Heart Failure Reviews

IS - 4

ER -

Natriuretic peptide hormone measurement in acute coronary syndrome

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this